» Articles » PMID: 23523148

Does Morbid Obesity Change Outcomes After Laparoscopic Surgery for Inflammatory Bowel Disease? Review of 626 Consecutive Cases

Overview
Journal J Am Coll Surg
Date 2013 Mar 26
PMID 23523148
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Little is known about the impact of obesity on morbidity in patients with inflammatory bowel disease (IBD) who are undergoing laparoscopic resections. The aim of this study was to evaluate outcomes in a consecutive series of normal weight (NW), overweight (OW), and obese (OB) patients undergoing elective laparoscopic colorectal surgery for IBD.

Study Design: This study is a retrospective analysis of a prospectively collected, Institutional Review Board-approved IBD database.

Results: Laparoscopic colorectal resection was performed in 626 patients (335 NW, 206 OW, and 85 OB) between August 2002 and December 2011. Operative time and blood loss were significantly higher in the OW and OB groups compared with the NW group (p = 0.001 and p < 0.001). No differences were observed in terms of intraoperative blood transfusions (p = 0.738) or complications (p = 0.196). The OW and OB groups had a significantly higher conversion rate (p = 0.049 and p = 0.037) and a longer incision compared with the NW group (p = 0.002 and p < 0.001). Obesity was an independent predictor of conversion to open surgery. No significant differences between groups were observed in terms of overall 30-day postoperative morbidity (p = 0.294) and mortality (p = 0.796). Long-term complications occurred in 6.3% NW, 7.3% OW, and 4.7% OB patients (p = 0.676). Incisional hernias were more common in the OB group compared with the NW group (p = 0.020). On multivariate analysis, obesity was not an independent risk factor for either early or late postoperative complications.

Conclusions: Obesity increases the complexity of laparoscopic resections in IBD with higher blood loss, operative time, and conversion rates, without worsening outcomes.

Citing Articles

Impact of Obesity and Metabolic Syndrome on IBD Outcomes.

Mahmoud M, Syn W Dig Dis Sci. 2024; 69(8):2741-2753.

PMID: 38864929 DOI: 10.1007/s10620-024-08504-8.


Evaluating body mass index's impact on Da Vinci Robotic rectal cancer surgery, a retrospective study.

Massala-Yila E, Ali M, Yu W, Wang W, Ren J, Wang D J Robot Surg. 2024; 18(1):22.

PMID: 38217775 DOI: 10.1007/s11701-023-01774-w.


Short-term postoperative outcomes for obese versus non-obese inflammatory bowel disease patients undergoing bowel resection: a propensity score matched analysis.

Park L, McKechnie T, Lee Y, Tessier L, Passos E, Doumouras A Int J Colorectal Dis. 2024; 39(1):17.

PMID: 38194054 DOI: 10.1007/s00384-023-04588-2.


The Impact of Obesity on Inflammatory Bowel Disease.

Kaazan P, Seow W, Yong S, Heilbronn L, Segal J Biomedicines. 2023; 11(12).

PMID: 38137477 PMC: 10740941. DOI: 10.3390/biomedicines11123256.


High Burden of Obesity and Low Rates of Weight Loss Pharmacotherapy in Inflammatory Bowel Disease: 10-Year Trend.

Elangovan A, Shah R, Ali S, Katz J, Cooper G Crohns Colitis 360. 2023; 5(2):otad007.

PMID: 36937138 PMC: 10022715. DOI: 10.1093/crocol/otad007.